Source: Annual Congress 2006 - The challenges of managing asthma in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. E. Shaw, M. A. Berry, M. Thomas, B. Hargadon, S. McKenna, M. J. Shelley, H. J. Pateman, R. H. Green, C. E. Brightling, A. J. Wardlaw, I. D. Pavord (Leicester, Aberdeen, United Kingdom). Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial. Eur Respir J 2006; 28: Suppl. 50, 3367

Member's Comments

No comment yet.

Related content which might interest you: Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: randomized parallel-group trial Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Exhaled nitric oxide correlations in patients with controlled and partially controlled asthma Source: Annual Congress 2012 - Asthma management Year: 2012 The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis Source: International Congress 2016 – Airway biomarkers Year: 2016 Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study Source: Eur Respir J 2014; 44: 1705-1707 Year: 2014 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010 Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study Source: Eur Respir J 2012; 39: 567-572 Year: 2012 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 The relationship between exhaled nitric oxide and body mass index in controlled an uncontrolled Tunisian asthmatics Source: International Congress 2016 – Airway biomarkers Year: 2016 Physical training does not increase allergic inflammation in asthmatic children Source: Eur Respir J 2008; 32: 1570-1575 Year: 2008 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 The effect of bronchodilation and spirometry on exhaled nitric oxide Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Exhaled nitric oxide may predict future benefit in patients with poorly controlled asthma Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Predicting response to corticosteroid in COPD using exhaled nitric oxide Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study Source: Eur Respir J 2011; 37: 523-531 Year: 2011 Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010